메뉴 건너뛰기




Volumn 8, Issue 1, 2005, Pages 43-47

The therapeutic value of SST-A octreotide alone or with adjuvant treatment in patients with advanced medullary thyroid carcinoma and positive 111In-octreotide scan

Author keywords

111In octreotide scintiscan; Medullary thyroid carcinoma; Somatostatin analog treatment; Somatostatin receptors in vivo

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; ETOPOSIDE; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SUCCIMER TC 99M;

EID: 19444362815     PISSN: 00258024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (29)
  • 1
    • 0005058478 scopus 로고    scopus 로고
    • Medullary thyroid carcinoma
    • Editions Nucleon Paris, Chapter
    • Schlumberger M, Pacini F. Medullary thyroid carcinoma. In: Thyroid tumors, Editions Nucleon Paris, 1999; Chapter 15, 267-299.
    • (1999) Thyroid Tumors , vol.15 , pp. 267-299
    • Schlumberger, M.1    Pacini, F.2
  • 2
    • 0024213731 scopus 로고
    • Oncological applications of somatostatin analogs
    • Schally AV. Oncological applications of somatostatin analogs. Cancer Res 1988, 48: 6977-6985.
    • (1988) Cancer Res. , vol.48 , pp. 6977-6985
    • Schally, A.V.1
  • 3
    • 0031784575 scopus 로고    scopus 로고
    • Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma
    • Mato E, Matias-Guiu X, Chico A, et al. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J Clin End Metab 1998; 83: 2417-2420.
    • (1998) J. Clin. End. Metab. , vol.83 , pp. 2417-2420
    • Mato, E.1    Matias-Guiu, X.2    Chico, A.3
  • 4
    • 0027336781 scopus 로고
    • Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs
    • G. Thieme Verlag, Stuttgart-New York
    • Doerr U, Wurm K, Horing E, et al. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs. In: Somatostatin receptor imaging, hormone and metabolic research, G. Thieme Verlag, Stuttgart-New York 1993; Suppl. 27: 36-43.
    • (1993) Somatostatin Receptor Imaging, Hormone and Metabolic Research , vol.27 , Issue.SUPPL. , pp. 36-43
    • Doerr, U.1    Wurm, K.2    Horing, E.3
  • 5
    • 0026041670 scopus 로고
    • The role of somatostatin and its analogs in the diagnosis and treatment of tumors
    • Lamberts S, Krenning E, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rew 1991; 12: 450-482.
    • (1991) Endocr. Rew. , vol.12 , pp. 450-482
    • Lamberts, S.1    Krenning, E.2    Reubi, J.C.3
  • 7
    • 0026378464 scopus 로고
    • Somatostatin receptors and somatostatin content in medullary thyroid carcinomas
    • Reubi JC, Chayvialle JA, Franc B, et al. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 1991; 64: 567-573.
    • (1991) Lab. Invest. , vol.64 , pp. 567-573
    • Reubi, J.C.1    Chayvialle, J.A.2    Franc, B.3
  • 8
    • 0025835957 scopus 로고
    • Radionuclide therapy revisited
    • Hoefnagel CA. Radionuclide therapy revisited. Eur J Nucl Med 1991; 18: 408-431.
    • (1991) Eur. J. Nucl. Med. , vol.18 , pp. 408-431
    • Hoefnagel, C.A.1
  • 9
    • 0035119335 scopus 로고    scopus 로고
    • Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units
    • Dotzenrath C, Goretzki P, Cupisti K, et al. Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units. Langenbeck's Arch Surg 2001; 386: 47-52.
    • (2001) Langenbeck's Arch. Surg. , vol.386 , pp. 47-52
    • Dotzenrath, C.1    Goretzki, P.2    Cupisti, K.3
  • 10
    • 0035027708 scopus 로고    scopus 로고
    • Effect of octreotide on proliferation of in vitro cultured thyroid medullary carcinoma cells
    • Zabel M, Gebarowska E, Drag-Zalesinska M, et al. Effect of octreotide on proliferation of in vitro cultured thyroid medullary carcinoma cells. Folia Histoch et Cytobiol 2001; 39: 185-186.
    • (2001) Folia Histoch. Et Cytobiol. , vol.39 , pp. 185-186
    • Zabel, M.1    Gebarowska, E.2    Drag-Zalesinska, M.3
  • 11
    • 0009708761 scopus 로고
    • Theory and practice of clinical trials
    • Holland JF, Frei III E, Bast Jr RC, et al (eds), 3rd edn, Lea & Febiger, Philadelphia-London; Chapter V, 1993
    • Zelen M. Theory and practice of clinical trials. In: Cancer medicine, Holland JF, Frei III E, Bast Jr RC, et al (eds), 3rd edn, Lea & Febiger, Philadelphia-London; 1993, Chapter V, pp 340-360, 1993.
    • (1993) Cancer Medicine , pp. 340-360
    • Zelen, M.1
  • 12
    • 0033503932 scopus 로고    scopus 로고
    • Patterns of nodal metastases in palpable medullary thyroid cancer
    • Molley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid cancer. Ann Surg 1999; 229: 880-888.
    • (1999) Ann. Surg. , vol.229 , pp. 880-888
    • Molley, J.F.1    DeBenedetti, M.K.2
  • 13
    • 0029681098 scopus 로고    scopus 로고
    • Langzeiterlauf des medullaeren Schilddruesenkarzinomes
    • Wagner HE, Ruchti C, Studer M, et al. Langzeiterlauf des medullaeren Schilddruesenkarzinomes. Swiss Surg 1996; 2: 181-186.
    • (1996) Swiss Surg. , vol.2 , pp. 181-186
    • Wagner, H.E.1    Ruchti, C.2    Studer, M.3
  • 14
    • 12544251995 scopus 로고
    • Calcitonin (CT) stimulation tests in the diagnosis and follow up of patients with medullary thyroid carcinoma (MTC)
    • Amsterdam/The Netherlands, September 5-19
    • Vainas I, Votsi M, Atmatzidis E, et al. Calcitonin (CT) stimulation tests in the diagnosis and follow up of patients with medullary thyroid carcinoma (MTC). Proceedings of Fourth International Congress on Hormones and Cancer, Amsterdam/The Netherlands, September 5-19, 1991: 379.
    • (1991) Proceedings of Fourth International Congress on Hormones and Cancer , pp. 379
    • Vainas, I.1    Votsi, M.2    Atmatzidis, E.3
  • 15
    • 0035078566 scopus 로고    scopus 로고
    • Octreotide in the management of hormone refractory prostate cancer
    • Vainas I. Octreotide in the management of hormone refractory prostate cancer. Chemotherapy 2001; 47, Suppl. 2: 109-126,
    • (2001) Chemotherapy , vol.47 , Issue.SUPPL. 2 , pp. 109-126
    • Vainas, I.1
  • 17
    • 0022878517 scopus 로고
    • Somatostatin analog: Effects on hypergastrinemia and hypercalcitoninemia
    • Geelhood GW, Bass BL, Mertz SL, et al. Somatostatin analog: effects on hypergastrinemia and hypercalcitoninemia. Surgery 1986; 100: 962-970.
    • (1986) Surgery , vol.100 , pp. 962-970
    • Geelhood, G.W.1    Bass, B.L.2    Mertz, S.L.3
  • 18
    • 0023181206 scopus 로고
    • Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion. A new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995
    • Jerkins TW, Sacks HS, O'Dorisio TM, et al. Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion. A new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995. J Clin Endocrinol Metab 1987; 64: 13413-13419.
    • (1987) J. Clin. Endocrinol. Metab. , vol.64 , pp. 13413-13419
    • Jerkins, T.W.1    Sacks, H.S.2    O'Dorisio, T.M.3
  • 19
    • 0022529091 scopus 로고
    • Treatment of APUDomas with long acting somatostatin analogue SMS 201-995
    • Schrezemeir J, Plewe G Sturmer W et al. Treatment of APUDomas with long acting somatostatin analogue SMS 201-995. Scand J Gastroenterol 1986; 119: 223-227.
    • (1986) Scand. J. Gastroenterol. , vol.119 , pp. 223-227
    • Schrezemeir, J.1    Plewe, G.2    Sturmer, W.3
  • 20
    • 0024520252 scopus 로고
    • Somatostatin in medullary thyroid cancer - In vitro and in vivo studies
    • Pacini F, Elisei R, Anelli S, et al. Somatostatin in medullary thyroid cancer - in vitro and in vivo studies. Cancer 1989; 63:1189-1195.
    • (1989) Cancer , vol.63 , pp. 1189-1195
    • Pacini, F.1    Elisei, R.2    Anelli, S.3
  • 21
    • 0018090610 scopus 로고
    • Somatostatin inhibits the pentagastrin induced release of serum calcitonin in medullary carcinoma of the thyroid
    • Gordin A, Lamberg BA, Pelkonen A, et al. Somatostatin inhibits the pentagastrin induced release of serum calcitonin in medullary carcinoma of the thyroid. Clin Endocrinol 1987; 8: 289-293.
    • (1987) Clin. Endocrinol. , vol.8 , pp. 289-293
    • Gordin, A.1    Lamberg, B.A.2    Pelkonen, A.3
  • 22
    • 0024325236 scopus 로고
    • Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma
    • Guliana JM, Guilliausseau PJ, Caron J, et al. Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma. Horm Metabol Res 1989; 21: 584-586.
    • (1989) Horm. Metabol. Res. , vol.21 , pp. 584-586
    • Guliana, J.M.1    Guilliausseau, P.J.2    Caron, J.3
  • 23
    • 0024951883 scopus 로고
    • Use of somatostatin analog SMS 201-995 in medullary thyroid carcinoma
    • Libroia A, Verga U, di Sacco G, et al. Use of somatostatin analog SMS 201-995 in medullary thyroid carcinoma. Henry Ford Hosp Med J 1989; 37: 151-153.
    • (1989) Henry Ford Hosp. Med. J. , vol.37 , pp. 151-153
    • Libroia, A.1    Verga, U.2    di Sacco, G.3
  • 24
    • 0034453062 scopus 로고    scopus 로고
    • Slow release lanreotide in combination with interferon-a2b in the treatment of symptomatic advanced medullary thyroid carcinoma
    • Vitaie G, Tagliaferri P, Caraglia M, et al. Slow release lanreotide in combination with interferon-a2b in the treatment of symptomatic advanced medullary thyroid carcinoma. J Clin End Metab 2000; 85: 983-988.
    • (2000) J. Clin. End. Metab. , vol.85 , pp. 983-988
    • Vitaie, G.1    Tagliaferri, P.2    Caraglia, M.3
  • 25
    • 0036796145 scopus 로고    scopus 로고
    • Somatostatin analogs in the treatment of medullary thyroid carcinoma
    • Diez JJ, Iglesias P. Somatostatin analogs in the treatment of medullary thyroid carcinoma. J Endocrinol Invest 2002; 25: 773-778.
    • (2002) J. Endocrinol. Invest. , vol.25 , pp. 773-778
    • Diez, J.J.1    Iglesias, P.2
  • 26
    • 0029768847 scopus 로고    scopus 로고
    • Somatostatin and somatostatin analogues in medullary thyroid carcinoma
    • O'Byrne KJ, O'Hare N, Sweeney E, et al. Somatostatin and somatostatin analogues in medullary thyroid carcinoma. Nucl Med Commun 1996; 17: 810-816.
    • (1996) Nucl. Med. Commun. , vol.17 , pp. 810-816
    • O'Byrne, K.J.1    O'Hare, N.2    Sweeney, E.3
  • 27
    • 0032980277 scopus 로고    scopus 로고
    • Quality of life in head and neck patients: Validation of the European Organization for Research and treatment of cancer quality of life questionnaire-H& N35
    • Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck patients: Validation of the European Organization for Research and treatment of cancer quality of life questionnaire-H& N35. J Clin Oncol. 1999; 17: 1008.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 1008
    • Bjordal, K.1    Hammerlid, E.2    Ahlner-Elmqvist, M.3
  • 28
    • 17544405207 scopus 로고    scopus 로고
    • External radiotherapy of thyroid cancer
    • Pöllinger B, Dühmke E. External radiotherapy of thyroid cancer. Onkologie 2001; 24: 134-138.
    • (2001) Onkologie , vol.24 , pp. 134-138
    • Pöllinger, B.1    Dühmke, E.2
  • 29
    • 19444371048 scopus 로고    scopus 로고
    • Combined radioimmunotherapy (RAIT) and chemotherapy (CH) in patients with medullary thyroid cancer (MTC): First clinical results
    • Juweid M, Rubin AD, Hajjar G, et al. Combined radioimmunotherapy (RAIT) and chemotherapy (CH) in patients with medullary thyroid cancer (MTC): first clinical results. Clin Cancer Res (Suppl) 1999; 5.
    • (1999) Clin. Cancer Res. , Issue.SUPPL. , pp. 5
    • Juweid, M.1    Rubin, A.D.2    Hajjar, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.